Page last updated: 2024-08-21

2-aminopurine and Neoplasms

2-aminopurine has been researched along with Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, CI; Dua, P; Kim, S; Lee, DK; Lee, TY; Li, CJ1
BERGER, RE; BIESELE, JJ; ELION, GB; HITCHINGS, GH; WILSON, AY1
BURCHENAL, JH; CRAVER, LF; DARGEON, HW; ESCHER, GC; KARNOFSKY, DA; KINGSLEY-PILLERS, EM; MYERS, WP; RHOADS, CP; SOUTHAM, CM1
Barrett, JC; Hesterberg, TW; Thomassen, DG1

Reviews

1 review(s) available for 2-aminopurine and Neoplasms

ArticleYear
Role of gene and chromosomal mutations in cell transformation.
    Annals of the New York Academy of Sciences, 1983, Volume: 407

    Topics: 2-Aminopurine; Animals; Asbestos; Carcinogens; Cell Transformation, Neoplastic; Cells, Cultured; Chromosome Aberrations; Diethylstilbestrol; Humans; Mutagenicity Tests; Mutation; Neoplasms; Precancerous Conditions

1983

Other Studies

3 other study(ies) available for 2-aminopurine and Neoplasms

ArticleYear
Long double-stranded RNA-mediated RNA interference and immunostimulation: long interfering double-stranded RNA as a potent anticancer therapeutics.
    Nucleic acid therapeutics, 2011, Volume: 21, Issue:3

    Topics: 2-Aminopurine; Antineoplastic Agents; Base Sequence; eIF-2 Kinase; Gene Expression; HeLa Cells; Humans; Immunization; Inhibitor of Apoptosis Proteins; Interferon-beta; Molecular Sequence Data; Molecular Structure; Neoplasms; RNA Interference; RNA, Double-Stranded; Survivin

2011
Studies on 2,6-diaminopurine and related substances in cultures of embryonic and sarcomatous rodent tissues.
    Cancer, 1951, Volume: 4, Issue:1

    Topics: 2-Aminopurine; Humans; Neoplasms; Purines; Sarcoma

1951
The effects of the folic acid antagonists and 2,6-diaminopurine on neoplastic disease, with special reference to acute leukemia.
    Cancer, 1951, Volume: 4, Issue:3

    Topics: 2-Aminopurine; Folic Acid Antagonists; Leukemia; Neoplasms; Purines

1951